Evidence map›Paper›PMID 16043680›Full record

Trial reportArchives of internal medicine2005

A randomized controlled trial of vitamin D3 supplementation in African American women.

John F Aloia, Sonia Arunabh Talwar, Simcha Pollack, James Yeh

Registry-linked trialOpen access · bronzeAbstract readClinical TrialRandomized Controlled Trial
In one paragraph

Trial report in Archives of internal medicine, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01333267 (Comparison of Skeletal and Mineral Metabolism Responses in Healthy African-Americans and Caucasians Using a Continuous Seven-Day Parathyroid Hormone), which is not on this map. Cited by 70 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 13 pooled it
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01333267 phase1withdrawnnot on this mapstarted 2015, after this paper: background citation

Comparison of Skeletal and Mineral Metabolism Responses in Healthy African-Americans and Caucasians Using a Continuous Seven-Day Parathyroid Hormone (PTH) or Parathyroid Hormone-related Protein (PTHrP) Infusion

TypeinterventionalSponsorUniversity of PittsburghRan2015 to 2017Enrolled0ConditionsOsteoporosis, Hypercalcemia of Malignancy, Hyperparathyroidism, Bone Diseases, EndocrineArmsParathyroid Hormone-related Protein (1-36), parathyroid hormone (1-34), PTH (1-34) and PTHrP (1-36)
3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 13 syntheses or guidelines pooled it, 187 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Vitamin D supplementation for prevention of mortality in adults.The Cochrane database of systematic reviews · 2014
    Pooled it
  12. Pooled it
  13. Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
    Pooled it
  14. Effect of vitamin D on bone strength in older African Americans: a randomized controlled trial.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2020
    Trial
  15. Three doses of vitamin D, bone mineral density, and geometry in older women during modest weight control in a 1-year randomized controlled trial.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2017
    Trial
  16. Trial
  17. Trial
  18. Effects of vitamin D supplementation in older African American women.The Journal of clinical endocrinology and metabolism · 2013
    Trial
  19. Trial
  20. The remodeling transient and the calcium economy.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2008
    Trial

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

John F AloiaDepartment of Medicine, Bone Mineral Research Center, Winthrop University Hospital, Mineola, NY 11501, USA. jaloia@winthrop.org
Sonia Arunabh Talwar
Simcha Pollack
James Yeh
Winthrop-University Hospital · US

Funding

VITAMIN D SUPPLEMENTATION IN POSTMENOPAUSAL WOMENR01AG015325 · NIA · WINTHROP-UNIVERSITY HOSPITAL · PI ALOIA, JOHN F. · 1998 to 2002
$666k
NIA NIH HHS R01 AG015325NIA NIH HHS R01 AG15325
6 · The paper itself

Abstract

backgroundWe conducted a randomized, placebo-controlled, double-blind trial to test the hypothesis that vitamin D(3) supplementation would prevent bone loss in calcium-replete, African American postmenopausal women.

methodsTwo hundred eight healthy black postmenopausal women, 50 to 75 years of age, were assigned to receive either placebo or 20 microg/d (800 IU) of vitamin D(3). Calcium supplements were provided to ensure a total calcium intake of 1200 to 1500 mg/d. After 2 years, the vitamin D(3) dose was increased to 50 microg/d (2000 IU) in the active group, and the study continued for an additional year. Bone mineral density (BMD) was measured every 6 months. Markers of bone turnover, vitamin D metabolites, and parathyroid hormone (PTH) levels were measured in serum.

resultsThere were no significant differences in BMD between the active and control groups throughout the study. There was also no relationship between serum 25-hydroxyvitamin D levels attained and rates of bone loss. There was an increase in BMD of the total body, hip, and radius at 1 year in both groups. Over the 3 years, BMD declined at these sites by 0.26% to 0.55% per year. The BMD of the lumbar spine increased slightly in the placebo and active groups. There were no persistent changes in serum PTH levels or the markers of bone turnover, although there was a transient decline in PTH in both groups at 3 months. No significant adverse events were attributed to vitamin D supplementation.

conclusionsThere was no observed effect of vitamin D(3) supplementation on bone loss or bone turnover markers in calcium-replete, postmenopausal African American women. Further studies are needed to determine if these findings are applicable to women of other ethnic groups.

Indexed as

Black or African AmericanBone DensityDietary SupplementsAgedBiomarkersCalciumCholecalciferolDouble-Blind MethodFemaleHumansMiddle AgedParathyroid HormonePostmenopauseTime FactorsTreatment OutcomeBiomarkersCalciumCholecalciferolParathyroid Hormone

Identifiers

PMID16043680
PMCPMC1464166
OpenAlexW2100626233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.